Article info
PDFDrug Information and Pharmacotherapy
DI-092 Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected patients and HIV coinfected patients
Citation
DI-092 Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected patients and HIV coinfected patients
Publication history
- First published February 24, 2014.
Online issue publication
September 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2014, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions